dimemorfan

This page covers all dimemorfan drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sigma non-opioid intracellular receptor 1.

Targets

Sigma non-opioid intracellular receptor 1

Phase 2 pipeline (1)

• Dimemorphan · Pain
  Dimemorfan works by activating opioid receptors in the brain to reduce pain perception.

Patent intelligence

• dimemorfan patent landscape — aggregated cliff calendar, attackable patents, originator estates